Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
3.860
-0.380 (-8.96%)
At close: Oct 31, 2025, 4:00 PM EDT
3.860
0.00 (0.00%)
After-hours: Oct 31, 2025, 4:00 PM EDT
Genfit Market Cap
Genfit has a market cap or net worth of $209.59 million as of October 31, 2025. Its market cap has decreased by -23.92% in one year.
Market Cap
209.59M
Enterprise Value
245.90M
1-Year Change
-23.92%
Ranking
Category
Stock Price
$3.86
Market Cap Chart
Since February 5, 2013, Genfit's market cap has increased from $103.68M to $209.59M, an increase of 102.15%. That is a compound annual growth rate of 5.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 207.80M | 13.86% |
| Dec 31, 2024 | 182.50M | -6.18% |
| Dec 29, 2023 | 194.52M | -7.62% |
| Dec 30, 2022 | 210.57M | -13.73% |
| Dec 31, 2021 | 244.08M | 28.79% |
| Dec 31, 2020 | 189.52M | -75.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.43B |
| Johnson & Johnson | 451.69B |
| AbbVie | 403.00B |
| UnitedHealth Group | 316.08B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 217.82B |